FDA Approved: PROMACTA — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved PROMACTA (eltrombopag olamine) under the original NDA for treatment of adults with chronic immune thrombocytopenia who have had an insufficient res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Promacta (eltrombopag)

Snippet

ORIG AP for PROMACTA (ELTROMBOPAG OLAMINE)